Related Experiment Video
Updated: Jun 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MEF/ELF4 transactivation by E2F1 is inhibited by p53
Manabu Taura1, Mary Ann Suico, Ryosuke Fukuda
1Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Global COE 'Cell Fate Regulation Research and Education Unit', Kumamoto University, Kumamoto 862-0973, Japan.
Abstract:
Myeloid elf-1-like factor (MEF) or Elf4 is an E-twenty-six (ETS)-related transcription factor with strong transcriptional activity that influences cellular senescence by affecting tumor suppressor p53. MEF downregulates p53 expression and inhibits p53-mediated cellular senescence by transcriptionally activating MDM2. However, whether p53 reciprocally opposes MEF remains unexplored. Here, we show that MEF is modulated by p53 in human cells and mice tissues. MEF expression and promoter activity were suppressed by p53. While we found that MEF promoter does not contain p53 response elements, intriguingly, it contains E2F consensus sites. Subsequently, we determined that E2F1 specifically binds to MEF promoter and transactivates MEF. Nevertheless, E2F1 DNA binding and transactivation of MEF promoter was inhibited by p53 through the association between p53 and E2F1. Furthermore, we showed that activation of p53 in doxorubicin-induced senescent cells increased E2F1 and p53 interaction, diminished E2F1 recruitment to MEF promoter and reduced MEF expression. These observations suggest that p53 downregulates MEF by associating with and inhibiting the binding activity of E2F1, a novel transcriptional activator of MEF. Together with previous findings, our present results indicate that a negative regulatory mechanism exists between p53 and MEF.
Insights
The tumor suppressor p53 inhibits myeloid elf-1-like factor (MEF) by blocking E2F1 binding to the MEF promoter. This reveals a novel negative regulatory mechanism between p53 and MEF in cellular senescence.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Myeloid elf-1-like factor (MEF), an ETS-related transcription factor, downregulates p53 and inhibits p53-mediated cellular senescence.
- The reciprocal regulation of MEF by p53 has not been previously investigated.
Purpose of the Study:
- To investigate the reciprocal regulatory relationship between p53 and MEF.
- To elucidate the mechanism by which p53 modulates MEF expression.
Main Methods:
- Analysis of MEF expression and promoter activity in human cells and mouse tissues.
- Identification of transcription factor binding sites on the MEF promoter.
- Investigation of p53 and E2F1 interaction and their effects on MEF promoter activity.
- Assessment of MEF expression in doxorubicin-induced senescent cells.
Main Results:
- p53 suppresses MEF expression and promoter activity.
- E2F1 binds to the MEF promoter and transactivates MEF.
- p53 inhibits E2F1 binding to the MEF promoter by forming a complex with E2F1.
- Activation of p53 reduces E2F1 recruitment to the MEF promoter and decreases MEF expression.
Conclusions:
- p53 negatively regulates MEF by inhibiting the transcriptional activator E2F1.
- A novel negative feedback loop between p53 and MEF is identified, contributing to the regulation of cellular senescence.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Negative Regulator Molecules
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

